Herpes Simplex Virus Infections Therapeutics - Pipeline Analysis 2017 - PowerPoint PPT Presentation

About This Presentation
Title:

Herpes Simplex Virus Infections Therapeutics - Pipeline Analysis 2017

Description:

The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development. – PowerPoint PPT presentation

Number of Views:70

less

Transcript and Presenter's Notes

Title: Herpes Simplex Virus Infections Therapeutics - Pipeline Analysis 2017


1
Herpes simplex virus infections Therapeutic
Pipeline Projects Vast Growth Ahead
2
Herpes Simplex Virus (HSV) Infections
According to a new research report Herpes
simplex virus infections Therapeutic Pipeline
Analysis, 2017 - Clinical Trials Results,
Patent, Designation, Collaboration, and Other
Developments published by PS Market Research,
Herpes simplex virus infections Therapeutic
pipeline currently exhibits a pipeline with 20
drug candidates. Access More About This Research
at https//www.psmarketresearch.com/market-analys
is/hsv-infections-therapeutics-pipeline-analysis
Herpes simplex virus infections Therapeutic
pipeline in 2017
The study analysed that the Herpes simplex virus
infections pipeline comprises of 20 drug
candidates in different stages of development.
3
Herpes Simplex Virus (HSV) Infections
Insights on pipeline segments
As per the findings of the research, most of the
drug candidates are being developed to be
administered by oral route.
New innovating technologies offer development of
promising drugs
Many technologies are being developed that offer
promising innovative treatments which can control
the progression of Herpes simplex virus
infections. The technologies include, but not
limited to, Vector based technology platform,
AdenoVerse technology platform, Juvaris
technology platform and Nanostat technology
platform.
4
Herpes Simplex Virus (HSV) Infections
Major companies collaborate for the development
of Herpes simplex virus infections Pipeline
The research found that various companies have
collaborated for the development of Herpes
simplex virus infections pipeline. In June 2014,
PaxVax Inc., entered into a research and
development collaboration with the University of
California to develop a combination vaccine to
prevent genital herpes simplex virus
infections. Some of the key players developing
drugs for the treatment of Herpes virus simplex
infections include Maruho Co., Ltd., NanoBio
Corporation, Lumavita AG and others.
5
Herpes Simplex Virus (HSV) Infections
Download report sample at
https//www.psmarketresearch.com/market-analysis/h
sv-infections-therapeutics-pipeline-analysis/repor
t-sample
6
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886
Write a Comment
User Comments (0)
About PowerShow.com